Enterostatin (VPDPR) and Its Peptide Fragment DPR Reduce Serum Cholesterol Levels after Oral Administration in Mice

DOI Web Site Web Site PubMed 被引用文献2件 参考文献24件
  • TAKENAKA Yasuyuki
    <i>Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University</i> Present address: <i>Department of Domestic Science, Kobe Shoin Woman's College</i>
  • NAKAMURA Futoshi
    <i>Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University</i> Present address: <i>R&D; Center, CALPIS Co., Ltd.</i>
  • YAMAMOTO Taichi
    <i>Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University</i> Present address: <i>Kikkoman R&D; division</i>
  • YOSHIKAWA Masaaki
    <i>Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University</i>

この論文をさがす

抄録

  We found that enterostatin (VPDPR), an anorexigenic peptide for a high-fat diet, significantly reduces serum cholesterol levels after oral administration of 100 mg/kg for 3 days in mice fed a high cholesterol-cholic acid diet. DPR, a peptide fragment of VPDPR, also had hypocholesterolemic activity at a dose of 50 mg/kg. Food intake was not suppressed under these dietary conditions. Fecal excretion of cholesterol and bile acids was increased significantly by both VPDPR and DPR. Interestingly, DPR induced hypocholesterolemic effects just two hours after a single oral administration at a dose of 100 mg/kg.<br>

収録刊行物

被引用文献 (2)*注記

もっと見る

参考文献 (24)*注記

もっと見る

関連プロジェクト

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ